Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip J Stephens

Showing results (121-130 of 168) with videos related to

Pageof 17
Sort By:
Plos One|November 28, 2018
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLCMichael E Goldberg, Meagan Montesion, Lauren Young, et al.
Oncology|October 21, 2016
Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 FusionVivek Subbiah, Oliver Holmes, Kyle Gowen, et al.
European Urology|July 8, 2015
Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic ProfilingSumanta K Pal, Toni K Choueiri, Kai Wang, et al.
Nature Communications|January 22, 2014
Kinase fusions are frequent in Spitz tumours and spitzoid melanomasThomas Wiesner, Jie He, Roman Yelensky, et al.
The Oncologist|October 29, 2017
<i>ALK</i> Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted TherapyJeffrey S Ross, Siraj M Ali, Omotayo Fasan, et al.
Blood|October 24, 2012
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genesLisa Giulino-Roth, Kai Wang, Theresa Y MacDonald, et al.
Journal of Hematology & Oncology|November 8, 2018
Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumorsCathy Zhou, Zilong Yuan, Weijie Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2016
Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic AlterationsKai Wang, Jeffery S Russell, Jessica D McDermott, et al.
Oncology|May 22, 2016
Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid CarcinomaAndreas M Heilmann, Vivek Subbiah, Kai Wang, et al.
Plos One|April 19, 2013
Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndromeSusan M Gribble, Frances K Wiseman, Stephen Clayton, et al.
Pageof 17

Showing results (121-130 of 168) with videos related to

Sort By:
Pageof 17
Plos One|November 28, 2018
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLCMichael E Goldberg, Meagan Montesion, Lauren Young, et al.
Oncology|October 21, 2016
Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 FusionVivek Subbiah, Oliver Holmes, Kyle Gowen, et al.
European Urology|July 8, 2015
Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic ProfilingSumanta K Pal, Toni K Choueiri, Kai Wang, et al.
Nature Communications|January 22, 2014
Kinase fusions are frequent in Spitz tumours and spitzoid melanomasThomas Wiesner, Jie He, Roman Yelensky, et al.
The Oncologist|October 29, 2017
<i>ALK</i> Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted TherapyJeffrey S Ross, Siraj M Ali, Omotayo Fasan, et al.
Blood|October 24, 2012
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genesLisa Giulino-Roth, Kai Wang, Theresa Y MacDonald, et al.
Journal of Hematology & Oncology|November 8, 2018
Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumorsCathy Zhou, Zilong Yuan, Weijie Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2016
Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic AlterationsKai Wang, Jeffery S Russell, Jessica D McDermott, et al.
Oncology|May 22, 2016
Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid CarcinomaAndreas M Heilmann, Vivek Subbiah, Kai Wang, et al.
Plos One|April 19, 2013
Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndromeSusan M Gribble, Frances K Wiseman, Stephen Clayton, et al.
Pageof 17